30 Aug 2022
O2 Power announces the addition of India-based Syngene, a pharma R&D company subsidiary of Biocon, as its newest C&I customer.
O2 Power has entered into a 74%-26% joint venture with Syngene, in order to supply them wind power from our hybrid plant in Karnataka.
The Syngene account adds to our growing portfolio of C&I customers. We are poised to build our C&I base both in Karnataka and in Maharashtra.
Read more
Back